Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): open-label, long-term extension of a phase 2b, randomised, placebo-controlled trial

Oliver Distler, Yannick Allanore, Christopher P. Denton, Masataka Kuwana, Marco Matucci-Cerinic, Janet E. Pope, Tatsuya Atsumi, Radim Bečvář, László Czirják, Eric Hachulla, Tomonori Ishii, Osamu Ishikawa, Sindhu R. Johnson, Ellen De Langhe, Chiara Stagnaro, Valeria Riccieri, Elena Schiopu, Richard M. Silver, Vanessa Smith, Virginia SteenWendy Stevens, Gabriella Szücs, Marie Elise Truchetet, Melanie Wosnitza, Kaisa Laapas, Frank Kramer, Dinesh Khanna

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): open-label, long-term extension of a phase 2b, randomised, placebo-controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences